Accelerated and intensified calcific atherosclerosis and microvascular dysfunction in patients with chronic kidney disease
Why the study?
CAD presents with atypical symptomatology and reduced response to established therapies in CKD, highlighting the need to understand unique features such as accelerated calcification and microvascular dysfunction.
Population
Patients with chronic kidney disease (CKD) and coronary artery disease (CAD)
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
May warrant heightened suspicion for silent ischemia in CKD; leaves open CKD-specific diagnostic and therapeutic trials.
Structured PICO
P
Population
Patients with chronic kidney disease (CKD) and coronary artery disease (CAD)
Coronary artery disease in patients with chronic kidney disease exhibits unique features, including accelerated calcification and microvascular dysfunction, which may contribute to atypical presentations and worse outcomes.
Cite This Study
Fakhry et al. (2020) studied this question.